Cost-effectiveness of FDG-PET
Estudo de Custo-efetividade Para o Sistema único de Saúde - SUS Sobre o Exame de Metabolismo de Glicose Marcada Com Flúor-18 Pela Tomografia de emissão de pósitron-PET
1 other identifier
observational
500
0 countries
N/A
Brief Summary
Evaluation of cost-effectiveness of FDG-PET for the public health system in Brazil.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2005
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
September 20, 2011
CompletedFirst Posted
Study publicly available on registry
September 21, 2011
CompletedSeptember 21, 2011
September 1, 2011
5 years
September 20, 2011
September 20, 2011
Conditions
Keywords
Study Arms (1)
oncologic patients
initial staging
Eligibility Criteria
500 oncologic patients
You may qualify if:
- Cancer
You may not qualify if:
- Other malignancy
- Uncontrolled Diabetes
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pesquisador executante
Study Record Dates
First Submitted
September 20, 2011
First Posted
September 21, 2011
Study Start
June 1, 2005
Primary Completion
June 1, 2010
Study Completion
September 1, 2011
Last Updated
September 21, 2011
Record last verified: 2011-09